Phase Angle and Mortality in Patients With Cirrhosis
Phase Angle as a Nutritional Marker Related to Prognosis Inpatients With Cirrhosis: A Cutt-off Value for Mexican Population
1 other identifier
observational
249
1 country
1
Brief Summary
A few PhA cut-off points have been proposed to define malnutrition in cirrhosis, and they have proven to be useful in prognosticating severity of the disease and mortality. However, PhA needs specific validation in different ethnic groups. The aim of this study was to evaluate the PhA cut-off value that would best define malnutrition and predict mortality in patients with liver cirrhosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 18, 2013
CompletedFirst Posted
Study publicly available on registry
December 30, 2013
CompletedNovember 18, 2014
November 1, 2014
5.5 years
December 18, 2013
November 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nutritional status
Phase angle obtained from bioelectrical impedance
Baseline
Other Outcomes (3)
Nutritional status
9 months
Nutritional status
18 months
Nutritional status
24 months
Study Arms (1)
Phase angle
Phase angle obtained from bioelectrical impedance
Eligibility Criteria
Population will be selected from the Liver Clinic at the Department of Gastroenterology in a tertiary care center in Mexico
You may qualify if:
- years old ambulatory patients Diagnosis of liver cirrhosis
You may not qualify if:
- Acute or chronic liver failure heart failure hepatocellular carcinoma pregnancy acute infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mexico City, Mexico City, 14000, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Aldo Torre, MD MSci
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- PRINCIPAL INVESTIGATOR
Astrid Ruiz-Margáin, B.Sci
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 18, 2013
First Posted
December 30, 2013
Study Start
January 1, 2008
Primary Completion
July 1, 2013
Study Completion
September 1, 2013
Last Updated
November 18, 2014
Record last verified: 2014-11